These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 15450130)
1. TLR2 and TLR4 stimulation differentially induce cytokine secretion in human neonatal, adult, and murine mononuclear cells. Schaub B; Bellou A; Gibbons FK; Velasco G; Campo M; He H; Liang Y; Gillman MW; Gold D; Weiss ST; Perkins DL; Finn PW J Interferon Cytokine Res; 2004 Sep; 24(9):543-52. PubMed ID: 15450130 [TBL] [Abstract][Full Text] [Related]
2. IL-10 released by concomitant TLR2 stimulation blocks the induction of a subset of Th1 cytokines that are specifically induced by TLR4 or TLR3 in human dendritic cells. Re F; Strominger JL J Immunol; 2004 Dec; 173(12):7548-55. PubMed ID: 15585882 [TBL] [Abstract][Full Text] [Related]
3. Toll-like receptor 4 or 2 agonists decrease allergic inflammation. Velasco G; Campo M; Manrique OJ; Bellou A; He H; Arestides RS; Schaub B; Perkins DL; Finn PW Am J Respir Cell Mol Biol; 2005 Mar; 32(3):218-24. PubMed ID: 15576672 [TBL] [Abstract][Full Text] [Related]
4. Neonatal immune responses to TLR2 stimulation: influence of maternal atopy on Foxp3 and IL-10 expression. Schaub B; Campo M; He H; Perkins D; Gillman MW; Gold DR; Weiss S; Lieberman E; Finn PW Respir Res; 2006 Mar; 7(1):40. PubMed ID: 16551363 [TBL] [Abstract][Full Text] [Related]
5. Toll-like receptor 4 mediates the antitumor host response induced by a 55-kilodalton protein isolated from Aeginetia indica L., a parasitic plant. Okamoto M; Oh-E G; Oshikawa T; Furuichi S; Tano T; Ahmed SU; Akashi S; Miyake K; Takeuchi O; Akira S; Himeno K; Sato M; Ohkubo S Clin Diagn Lab Immunol; 2004 May; 11(3):483-95. PubMed ID: 15138173 [TBL] [Abstract][Full Text] [Related]
6. Microbial Toll-like receptor ligands differentially regulate CXCL10/IP-10 expression in fibroblasts and mononuclear leukocytes in synergy with IFN-gamma and provide a mechanism for enhanced synovial chemokine levels in septic arthritis. Proost P; Vynckier AK; Mahieu F; Put W; Grillet B; Struyf S; Wuyts A; Opdenakker G; Van Damme J Eur J Immunol; 2003 Nov; 33(11):3146-53. PubMed ID: 14579283 [TBL] [Abstract][Full Text] [Related]
7. Selective priming to Toll-like receptor 4 (TLR4), not TLR2, ligands by P. acnes involves up-regulation of MD-2 in mice. Romics L; Dolganiuc A; Kodys K; Drechsler Y; Oak S; Velayudham A; Mandrekar P; Szabo G Hepatology; 2004 Sep; 40(3):555-64. PubMed ID: 15349893 [TBL] [Abstract][Full Text] [Related]
8. TLR2 and TLR4 co-activation utilizes distinct signaling pathways for the production of Th1/Th2/Th17 cytokines in neonatal immune cells. Sugitharini V; Shahana P; Prema A; Berla Thangam E Cytokine; 2016 Sep; 85():191-200. PubMed ID: 27380627 [TBL] [Abstract][Full Text] [Related]
9. Toll-like receptor 2 ligands activate human basophils for both IgE-dependent and IgE-independent secretion. Bieneman AP; Chichester KL; Chen YH; Schroeder JT J Allergy Clin Immunol; 2005 Feb; 115(2):295-301. PubMed ID: 15696084 [TBL] [Abstract][Full Text] [Related]
10. Type 1 cytokine/chemokine production by mouse NK cells following activation of their TLR/MyD88-mediated pathways. Sawaki J; Tsutsui H; Hayashi N; Yasuda K; Akira S; Tanizawa T; Nakanishi K Int Immunol; 2007 Mar; 19(3):311-20. PubMed ID: 17289654 [TBL] [Abstract][Full Text] [Related]
11. In vitro responsiveness to IL-18 in combination with IL-12 or IL-2 by PBMC from patients with bronchial asthma and atopic dermatitis. El-Mezayen RE; Matsumoto T Clin Immunol; 2004 Apr; 111(1):61-8. PubMed ID: 15093553 [TBL] [Abstract][Full Text] [Related]
12. Involvement of levels of Toll like receptor-4 in monocytes, CD4+ T-lymphocyte subsets, and cytokines in patients with immune thrombocytopenic purpura. Liu H; Ouyang X; Li Y; Zeng H; Wang X; Xie S; Nie D; Xiao J; Wei J; Wu Y; Yin S; Ma L Thromb Res; 2013 Aug; 132(2):196-201. PubMed ID: 23830211 [TBL] [Abstract][Full Text] [Related]
13. The Toll-like receptor-2/6 agonist macrophage-activating lipopeptide-2 cooperates with IFN-gamma to reverse the Th2 skew in an in vitro allergy model. Weigt H; Muhlradt PF; Larbig M; Krug N; Braun A J Immunol; 2004 May; 172(10):6080-6. PubMed ID: 15128792 [TBL] [Abstract][Full Text] [Related]
14. Surfactant protein D deficiency influences allergic immune responses. Schaub B; Westlake RM; He H; Arestides R; Haley KJ; Campo M; Velasco G; Bellou A; Hawgood S; Poulain FR; Perkins DL; Finn PW Clin Exp Allergy; 2004 Dec; 34(12):1819-26. PubMed ID: 15663554 [TBL] [Abstract][Full Text] [Related]
15. Neonatal innate cytokine responses to BCG controlling T-cell development vary between populations. van den Biggelaar AH; Prescott SL; Roponen M; Nadal-Sims MA; Devitt CJ; Phuanukoonnon S; Pomat W; Tulic MK; Lehmann D; Siba PM; Richmond PC; Holt PG J Allergy Clin Immunol; 2009 Sep; 124(3):544-50, 550.e1-2. PubMed ID: 19500827 [TBL] [Abstract][Full Text] [Related]
16. Ability of supragingival plaque to induce toll-like receptor 4-mediated stimulation is associated with cytokine production by peripheral blood mononuclear cells. Yamaguchi R; Yoshimura A; Yoshioka H; Kaneko T; Hara Y J Periodontol; 2009 Mar; 80(3):512-20. PubMed ID: 19254136 [TBL] [Abstract][Full Text] [Related]
17. NOD2 mediates anti-inflammatory signals induced by TLR2 ligands: implications for Crohn's disease. Netea MG; Kullberg BJ; de Jong DJ; Franke B; Sprong T; Naber TH; Drenth JP; Van der Meer JW Eur J Immunol; 2004 Jul; 34(7):2052-9. PubMed ID: 15214053 [TBL] [Abstract][Full Text] [Related]
18. Differential cytokine production and Toll-like receptor signaling pathways by Candida albicans blastoconidia and hyphae. van der Graaf CA; Netea MG; Verschueren I; van der Meer JW; Kullberg BJ Infect Immun; 2005 Nov; 73(11):7458-64. PubMed ID: 16239547 [TBL] [Abstract][Full Text] [Related]